LS-P-POPPY

A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants With Advanced Solid Tumors

Status:

OPEN TO ACCRUAL

Trial Type:
Breast, Head and Neck, Thoracic
Age Group:
Adults
Phase:

I

NCT Number:

NCT05720117

Contact:

Carneiro, Benedito

benedito.carneiro@BrownHealth.org